Page 42
Notes:
allied
academies
Res Rep Gynaecol Obstet 2017 | Volume 1 Issue 4
November 02-03, 2017 | Chicago, USA
Embryology and In vitro Fertilization
World Congress on
Management of dysfunctional uterine bleeding (DUB)
Sujata Sanjay
Sanjay, Orthopaedic, Spine and Maternity Centre, India
A
bnormal uterine bleeding is the common presenting
complains in the Gynaecology outpatient department
in all age groups. Dysfunctional uterine bleeding (DUB)
is the diagnosis given to women with abnormal uterine
bleeding in whom no clear etiology can be identified. DUB
has been observed in both ovulatory and anovulatory
cycles. Nonsteroidal anti-inflammatory drugs such as
mefenamic acid or indomethacin will be the first choice
for many women as they have few side effects and it is
only necessary to take them when menstrual bleeding
occurs. When contraception is also required, combined
oral contraceptives are helpful. Progestogen and danazol
therapy are also effective, although side effects do occur. A
new development has been the levonorgestrel-containing
intrauterine contraceptive device which has been shown to
result in large decreases in menstrual blood loss. For those
women who would like a surgical approach but do not want
to undergo hysterectomy, the relatively new technique of
endometrial resection results either in amenorrhoea or
reduced menstrual blood loss in the majority of women.
Adolescent DUB is due to immaturity of the hypothalamus
and pituitary and menstrual cycles may be anovulatory.
In teenage girls organic disease is rare and DUB usually
gets resolved spontaneously. That’s why they are treated
expectantly and curettage is often delayed. In the middle
years of reproductive life (20-39yrs), benign organic disease
is common, and curettage is usually performed to exclude
complications of pregnancy and other disease. Conservative
therapy is usually indicated, though hysterectomy may
be indicated if bleeding is severe or recurrent and patient
has completed her family. Perimenopausal DUB is due
to the decreased number of ovarian follicles and their
increased resistance to gonadotrophin stimulation, there is
a possibility of malignancy. So, these women should always
be investigated by curettage or hysteroscopy without delay.
Although conservative therapy may be tried as a temporizing
measure, hysterectomy is often indicated
Speaker Biography
Dr. Sujata Sanjay is not only an eminent and highly proficient and capable doctor
of repute, but she is also sincerely dedicated to the cause of the poor people and
particularly to those of the backward areas like Uttarakhand, where poverty reigns
supreme and the people are virtually deprived of even ordinary medical. Dr. Sujata
Sanjay has within a period of 6 year, treated more than 5800 patients in 201 free
medical camps which have been regularly organized in the state of Uttarakhand.
Her simple and sympathetic nature towards patients has been appreciated and has
helped her establish her name in Uttarakhand. Dr Sujata had been awarded “# 100
WOMEN ACHIEVERS AWARD” By Ministry of Women and Child Development (MWCD),
Government of India. Awarded by President of India, Shri. Pranab Mukherjee, at
Rashtrapati Bhawan, New Delhi on January 22 2016) only gynecologist from all over
India “FOGSI the Padmashree Kamlabai Hospet Award” At 59th All India Congress of
Obstetrics & Gynaecology (AICOG) at Agra Jan 2016 (First time for Uttarakhand )
e:
drsujatasanjay@gmail.com